Primary endpoint
| | | | | | |
1/Modified GCPS score (without B)
|
1.12
|
0.08
|
0.97*
|
1.29
|
0.12
|
<.0001**
|
1/Unmodified GCPS score (with B)
|
1.13
|
0.09
|
0.96*
|
1.32
|
0.13
|
0.0005**
|
Secondary endpoints
| | | | | | |
1/Pain at rest
|
1.19
|
0.16
|
0.91*
|
1.55
|
0.20
|
<.0001**
|
1/Pain at palpation/manipulation
|
1.18
|
0.18
|
0.87*
|
1.58
|
0.28
|
0.0049**
|
1/Global efficacy score
|
1.08
|
0.07
|
0.94*
|
1.23
|
0.28
|
<.0001**
|
1/Global inflammation score
|
1.31
|
0.23
|
0.93*
|
1.85
|
0.12
|
0.058
|
1/Owner assessment: demeanor
|
1.00
|
0.02
|
0.95*
|
1.05
|
0.96
|
0.010**
|
1/Owner assessment: mobility
|
0.95
|
0.03
|
0.89*
|
1.02
|
0.17
|
0.010**
|